Tech billionaires like Jeff Bezos, Sam Altman, and Peter Thiel are betting big on extending life. They're investing millions in labs that aim to reverse aging and add years to our lives. But it's not all smooth sailing. These anti-aging enthusiasts face regulatory hurdles, ethical questions, and long-term funding concerns.

David Gobel, the CEO of Methuselah Foundation, says their mission is to save lives, not make dollars. His non-profit has projects like reviving brain fluid flow to fight Alzheimer's and preserving organs with subzero tech for better transplants. But getting these innovations to market isn't easy. It takes time and lots of money.

The FDA takes about 12 years to approve a new drug. And they don't even consider aging a disease. So, don't expect an anti-aging pill anytime soon. Gobel thinks we might see something like a 'Star Trek' teleportation pod that remodels us by 2060.

But there are ethical dilemmas too. Who gets these therapies, and when? Some treatments might help older people but harm younger ones. And researchers worry about targeting single diseases when health involves all organs.

Experts like Dr. Joshua Chodosh say environmental factors play a big role in longevity. Better diets, exercise, and cleaner environments could extend our healthy years more than any pill.

The Billionaire's Quest: Can We Hack Aging?

Actions